nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—CDK2—asthma	0.358	0.816	CbGaD
Bosutinib—EGFR—asthma	0.0806	0.184	CbGaD
Bosutinib—ABCB1—Fluticasone furoate—asthma	0.0102	0.0883	CbGbCtD
Bosutinib—ABCB1—Indacaterol—asthma	0.00829	0.072	CbGbCtD
Bosutinib—CYP3A4—Fluticasone furoate—asthma	0.00609	0.0529	CbGbCtD
Bosutinib—CYP3A4—Budesonide—asthma	0.00543	0.0472	CbGbCtD
Bosutinib—CYP3A4—Ciclesonide—asthma	0.00497	0.0431	CbGbCtD
Bosutinib—CYP3A4—Indacaterol—asthma	0.00497	0.0431	CbGbCtD
Bosutinib—CYP3A4—Salbutamol—asthma	0.00462	0.0401	CbGbCtD
Bosutinib—CYP3A4—Salmeterol—asthma	0.00462	0.0401	CbGbCtD
Bosutinib—CYP3A4—Flunisolide—asthma	0.00462	0.0401	CbGbCtD
Bosutinib—ABCB1—Loratadine—asthma	0.00443	0.0384	CbGbCtD
Bosutinib—CYP3A4—Ipratropium bromide—asthma	0.00412	0.0357	CbGbCtD
Bosutinib—CYP3A4—Zileuton—asthma	0.00412	0.0357	CbGbCtD
Bosutinib—ABCB1—Methylprednisolone—asthma	0.00405	0.0352	CbGbCtD
Bosutinib—CYP3A4—Fluticasone Propionate—asthma	0.00393	0.0341	CbGbCtD
Bosutinib—CYP3A4—Zafirlukast—asthma	0.00362	0.0315	CbGbCtD
Bosutinib—CYP3A4—Tiotropium—asthma	0.00312	0.0271	CbGbCtD
Bosutinib—CYP3A4—Aminophylline—asthma	0.00298	0.0258	CbGbCtD
Bosutinib—CYP3A4—Theophylline—asthma	0.0028	0.0243	CbGbCtD
Bosutinib—CYP3A4—Loratadine—asthma	0.00265	0.023	CbGbCtD
Bosutinib—CYP3A4—Montelukast—asthma	0.00265	0.023	CbGbCtD
Bosutinib—ABCB1—Betamethasone—asthma	0.00263	0.0229	CbGbCtD
Bosutinib—ABCB1—Prednisolone—asthma	0.0026	0.0226	CbGbCtD
Bosutinib—ABCB1—Hydrocortisone—asthma	0.00246	0.0214	CbGbCtD
Bosutinib—ABCB1—Prednisone—asthma	0.00245	0.0213	CbGbCtD
Bosutinib—CYP3A4—Methylprednisolone—asthma	0.00243	0.0211	CbGbCtD
Bosutinib—CYP3A4—Triamcinolone—asthma	0.00184	0.016	CbGbCtD
Bosutinib—CYP3A4—Betamethasone—asthma	0.00158	0.0137	CbGbCtD
Bosutinib—CYP3A4—Prednisolone—asthma	0.00156	0.0135	CbGbCtD
Bosutinib—ABCB1—Dexamethasone—asthma	0.00153	0.0133	CbGbCtD
Bosutinib—CYP3A4—Hydrocortisone—asthma	0.00148	0.0128	CbGbCtD
Bosutinib—CYP3A4—Prednisone—asthma	0.00147	0.0128	CbGbCtD
Bosutinib—CYP3A4—Dexamethasone—asthma	0.000918	0.00797	CbGbCtD
Bosutinib—PTK2—Pentoxifylline—Dyphylline—asthma	0.000791	0.236	CbGdCrCtD
Bosutinib—Vandetanib—VEGFA—asthma	0.000762	0.315	CrCbGaD
Bosutinib—Vandetanib—EGFR—asthma	0.000643	0.266	CrCbGaD
Bosutinib—Gefitinib—EGFR—asthma	0.000611	0.253	CrCbGaD
Bosutinib—NUAK2—trachea—asthma	0.00028	0.00245	CbGeAlD
Bosutinib—BCR—trachea—asthma	0.00028	0.00245	CbGeAlD
Bosutinib—CSNK1A1—cardiovascular system—asthma	0.000279	0.00244	CbGeAlD
Bosutinib—IRAK4—adrenal cortex—asthma	0.000279	0.00244	CbGeAlD
Bosutinib—CSNK1E—bronchus—asthma	0.000278	0.00243	CbGeAlD
Bosutinib—STK24—adrenal gland—asthma	0.000277	0.00242	CbGeAlD
Bosutinib—CLK1—cardiovascular system—asthma	0.000277	0.00242	CbGeAlD
Bosutinib—PTK2B—smooth muscle tissue—asthma	0.000276	0.00241	CbGeAlD
Bosutinib—SIK1—bronchus—asthma	0.000273	0.00239	CbGeAlD
Bosutinib—IRAK4—bronchus—asthma	0.000273	0.00239	CbGeAlD
Bosutinib—ULK3—adrenal cortex—asthma	0.000273	0.00238	CbGeAlD
Bosutinib—ERBB3—epithelium—asthma	0.000272	0.00238	CbGeAlD
Bosutinib—CAMK2G—cardiovascular system—asthma	0.000272	0.00238	CbGeAlD
Bosutinib—CSK—trachea—asthma	0.000271	0.00237	CbGeAlD
Bosutinib—EPHA4—bronchus—asthma	0.000271	0.00236	CbGeAlD
Bosutinib—CSNK1A1—trachea—asthma	0.000269	0.00235	CbGeAlD
Bosutinib—FER—adrenal gland—asthma	0.000268	0.00234	CbGeAlD
Bosutinib—MAP3K7—adrenal cortex—asthma	0.000268	0.00234	CbGeAlD
Bosutinib—STK25—lung—asthma	0.000268	0.00234	CbGeAlD
Bosutinib—HCK—trachea—asthma	0.000267	0.00234	CbGeAlD
Bosutinib—CLK1—trachea—asthma	0.000267	0.00234	CbGeAlD
Bosutinib—MAP2K2—bronchus—asthma	0.000267	0.00234	CbGeAlD
Bosutinib—ULK3—bronchus—asthma	0.000267	0.00234	CbGeAlD
Bosutinib—EPHA3—lung—asthma	0.000266	0.00232	CbGeAlD
Bosutinib—TBK1—adrenal cortex—asthma	0.000265	0.00232	CbGeAlD
Bosutinib—PTK2—epithelium—asthma	0.000264	0.00231	CbGeAlD
Bosutinib—MAP3K7—bronchus—asthma	0.000263	0.0023	CbGeAlD
Bosutinib—MAP4K1—adrenal gland—asthma	0.000263	0.0023	CbGeAlD
Bosutinib—PTK2B—cardiovascular system—asthma	0.000263	0.0023	CbGeAlD
Bosutinib—BTK—adrenal gland—asthma	0.000262	0.00229	CbGeAlD
Bosutinib—MAP2K2—smooth muscle tissue—asthma	0.000262	0.00229	CbGeAlD
Bosutinib—PLK2—lung—asthma	0.00026	0.00227	CbGeAlD
Bosutinib—PTK2—bronchus—asthma	0.00026	0.00227	CbGeAlD
Bosutinib—TBK1—bronchus—asthma	0.00026	0.00227	CbGeAlD
Bosutinib—SIK3—lung—asthma	0.000258	0.00226	CbGeAlD
Bosutinib—TNK2—adrenal gland—asthma	0.000258	0.00225	CbGeAlD
Bosutinib—MAP3K7—smooth muscle tissue—asthma	0.000257	0.00225	CbGeAlD
Bosutinib—RPS6KB1—adrenal cortex—asthma	0.000255	0.00223	CbGeAlD
Bosutinib—IRAK1—bronchus—asthma	0.000255	0.00223	CbGeAlD
Bosutinib—PTK2—smooth muscle tissue—asthma	0.000254	0.00222	CbGeAlD
Bosutinib—MAP4K2—adrenal gland—asthma	0.000254	0.00222	CbGeAlD
Bosutinib—YES1—respiratory system—asthma	0.000254	0.00222	CbGeAlD
Bosutinib—RPS6KB1—epithelium—asthma	0.000254	0.00222	CbGeAlD
Bosutinib—AXL—adrenal cortex—asthma	0.000252	0.00221	CbGeAlD
Bosutinib—STK10—respiratory system—asthma	0.000252	0.0022	CbGeAlD
Bosutinib—TAOK3—respiratory system—asthma	0.000251	0.00219	CbGeAlD
Bosutinib—STK3—adrenal gland—asthma	0.000251	0.00219	CbGeAlD
Bosutinib—RPS6KB1—bronchus—asthma	0.00025	0.00218	CbGeAlD
Bosutinib—CSNK1E—trachea—asthma	0.000249	0.00218	CbGeAlD
Bosutinib—IRAK1—smooth muscle tissue—asthma	0.000249	0.00218	CbGeAlD
Bosutinib—STK4—lung—asthma	0.000249	0.00217	CbGeAlD
Bosutinib—MAP2K2—cardiovascular system—asthma	0.000249	0.00217	CbGeAlD
Bosutinib—LCK—bronchus—asthma	0.000248	0.00217	CbGeAlD
Bosutinib—CAMK1D—lung—asthma	0.000246	0.00215	CbGeAlD
Bosutinib—IRAK4—trachea—asthma	0.000245	0.00214	CbGeAlD
Bosutinib—RPS6KB1—smooth muscle tissue—asthma	0.000245	0.00214	CbGeAlD
Bosutinib—SRC—respiratory system—asthma	0.000244	0.00214	CbGeAlD
Bosutinib—STK24—lung—asthma	0.000243	0.00212	CbGeAlD
Bosutinib—EPHA4—trachea—asthma	0.000243	0.00212	CbGeAlD
Bosutinib—SLK—adrenal cortex—asthma	0.000243	0.00212	CbGeAlD
Bosutinib—AXL—smooth muscle tissue—asthma	0.000242	0.00212	CbGeAlD
Bosutinib—PTK2—cardiovascular system—asthma	0.000242	0.00211	CbGeAlD
Bosutinib—TBK1—cardiovascular system—asthma	0.000242	0.00211	CbGeAlD
Bosutinib—EPHB4—adrenal cortex—asthma	0.000241	0.00211	CbGeAlD
Bosutinib—ERBB3—trachea—asthma	0.000241	0.0021	CbGeAlD
Bosutinib—BMPR2—adrenal gland—asthma	0.00024	0.0021	CbGeAlD
Bosutinib—EPHB4—epithelium—asthma	0.00024	0.0021	CbGeAlD
Bosutinib—ULK3—trachea—asthma	0.00024	0.0021	CbGeAlD
Bosutinib—STK36—adrenal gland—asthma	0.000239	0.00208	CbGeAlD
Bosutinib—EPHB3—adrenal gland—asthma	0.000239	0.00208	CbGeAlD
Bosutinib—SLK—bronchus—asthma	0.000238	0.00208	CbGeAlD
Bosutinib—EPHA2—adrenal cortex—asthma	0.000237	0.00207	CbGeAlD
Bosutinib—EPHB4—bronchus—asthma	0.000237	0.00207	CbGeAlD
Bosutinib—MAP3K7—trachea—asthma	0.000236	0.00206	CbGeAlD
Bosutinib—MERTK—adrenal gland—asthma	0.000236	0.00206	CbGeAlD
Bosutinib—EPHA2—epithelium—asthma	0.000236	0.00206	CbGeAlD
Bosutinib—ALK—lung—asthma	0.000235	0.00205	CbGeAlD
Bosutinib—FER—lung—asthma	0.000235	0.00205	CbGeAlD
Bosutinib—TBK1—trachea—asthma	0.000233	0.00204	CbGeAlD
Bosutinib—PTK2—trachea—asthma	0.000233	0.00204	CbGeAlD
Bosutinib—RPS6KB1—cardiovascular system—asthma	0.000233	0.00203	CbGeAlD
Bosutinib—EPHA2—bronchus—asthma	0.000232	0.00203	CbGeAlD
Bosutinib—FYN—bronchus—asthma	0.000232	0.00202	CbGeAlD
Bosutinib—EPHB4—smooth muscle tissue—asthma	0.000231	0.00202	CbGeAlD
Bosutinib—MAP4K4—adrenal gland—asthma	0.000231	0.00202	CbGeAlD
Bosutinib—FGR—cardiovascular system—asthma	0.000231	0.00202	CbGeAlD
Bosutinib—MAP3K3—adrenal cortex—asthma	0.000231	0.00202	CbGeAlD
Bosutinib—MAP4K1—lung—asthma	0.00023	0.00201	CbGeAlD
Bosutinib—MAP3K19—lung—asthma	0.00023	0.00201	CbGeAlD
Bosutinib—AXL—cardiovascular system—asthma	0.00023	0.00201	CbGeAlD
Bosutinib—BCR—adrenal gland—asthma	0.00023	0.00201	CbGeAlD
Bosutinib—NUAK2—adrenal gland—asthma	0.00023	0.00201	CbGeAlD
Bosutinib—BTK—lung—asthma	0.000229	0.002	CbGeAlD
Bosutinib—MAP3K12—adrenal gland—asthma	0.000228	0.00199	CbGeAlD
Bosutinib—FYN—smooth muscle tissue—asthma	0.000227	0.00198	CbGeAlD
Bosutinib—MAP3K3—bronchus—asthma	0.000226	0.00198	CbGeAlD
Bosutinib—MAP4K5—bronchus—asthma	0.000226	0.00198	CbGeAlD
Bosutinib—TNK2—lung—asthma	0.000226	0.00197	CbGeAlD
Bosutinib—RPS6KB1—trachea—asthma	0.000224	0.00196	CbGeAlD
Bosutinib—MAP2K1—adrenal gland—asthma	0.000223	0.00195	CbGeAlD
Bosutinib—STK35—adrenal gland—asthma	0.000223	0.00195	CbGeAlD
Bosutinib—LCK—trachea—asthma	0.000223	0.00195	CbGeAlD
Bosutinib—MAP4K2—lung—asthma	0.000223	0.00195	CbGeAlD
Bosutinib—AXL—trachea—asthma	0.000222	0.00194	CbGeAlD
Bosutinib—CSK—adrenal gland—asthma	0.000222	0.00194	CbGeAlD
Bosutinib—MAP4K5—smooth muscle tissue—asthma	0.000221	0.00194	CbGeAlD
Bosutinib—CSNK1A1—adrenal gland—asthma	0.000221	0.00193	CbGeAlD
Bosutinib—EPHB4—cardiovascular system—asthma	0.00022	0.00192	CbGeAlD
Bosutinib—ERBB4—lung—asthma	0.00022	0.00192	CbGeAlD
Bosutinib—STK3—lung—asthma	0.00022	0.00192	CbGeAlD
Bosutinib—CSF1R—respiratory system—asthma	0.000219	0.00192	CbGeAlD
Bosutinib—HCK—adrenal gland—asthma	0.000219	0.00192	CbGeAlD
Bosutinib—CLK1—adrenal gland—asthma	0.000219	0.00192	CbGeAlD
Bosutinib—ABL2—adrenal gland—asthma	0.000218	0.0019	CbGeAlD
Bosutinib—ROCK1—lung—asthma	0.000217	0.0019	CbGeAlD
Bosutinib—EPHA2—cardiovascular system—asthma	0.000216	0.00189	CbGeAlD
Bosutinib—FYN—cardiovascular system—asthma	0.000216	0.00188	CbGeAlD
Bosutinib—CAMK2G—adrenal gland—asthma	0.000215	0.00188	CbGeAlD
Bosutinib—BMP2K—adrenal gland—asthma	0.000215	0.00188	CbGeAlD
Bosutinib—SLK—trachea—asthma	0.000214	0.00187	CbGeAlD
Bosutinib—LRRK2—adrenal gland—asthma	0.000213	0.00186	CbGeAlD
Bosutinib—YES1—adrenal cortex—asthma	0.000213	0.00186	CbGeAlD
Bosutinib—EGFR—adrenal gland—asthma	0.000213	0.00186	CbGeAlD
Bosutinib—EPHB4—trachea—asthma	0.000212	0.00186	CbGeAlD
Bosutinib—BMPR2—lung—asthma	0.000211	0.00184	CbGeAlD
Bosutinib—MAP3K3—cardiovascular system—asthma	0.000211	0.00184	CbGeAlD
Bosutinib—TAOK3—adrenal cortex—asthma	0.00021	0.00184	CbGeAlD
Bosutinib—YES1—bronchus—asthma	0.000209	0.00183	CbGeAlD
Bosutinib—STK36—lung—asthma	0.000209	0.00183	CbGeAlD
Bosutinib—EPHB3—lung—asthma	0.000209	0.00183	CbGeAlD
Bosutinib—EPHA2—trachea—asthma	0.000208	0.00182	CbGeAlD
Bosutinib—FYN—trachea—asthma	0.000208	0.00182	CbGeAlD
Bosutinib—PTK2B—adrenal gland—asthma	0.000208	0.00182	CbGeAlD
Bosutinib—STK10—bronchus—asthma	0.000207	0.00181	CbGeAlD
Bosutinib—MERTK—lung—asthma	0.000207	0.00181	CbGeAlD
Bosutinib—TAOK3—bronchus—asthma	0.000206	0.0018	CbGeAlD
Bosutinib—Vandetanib—ALB—asthma	0.000205	0.0848	CrCbGaD
Bosutinib—YES1—smooth muscle tissue—asthma	0.000205	0.00179	CbGeAlD
Bosutinib—CSNK1E—adrenal gland—asthma	0.000204	0.00179	CbGeAlD
Bosutinib—SRC—epithelium—asthma	0.000204	0.00178	CbGeAlD
Bosutinib—MAP3K3—trachea—asthma	0.000203	0.00178	CbGeAlD
Bosutinib—MAP4K5—trachea—asthma	0.000203	0.00178	CbGeAlD
Bosutinib—MAP4K4—lung—asthma	0.000203	0.00177	CbGeAlD
Bosutinib—BCR—lung—asthma	0.000201	0.00176	CbGeAlD
Bosutinib—NUAK2—lung—asthma	0.000201	0.00176	CbGeAlD
Bosutinib—IRAK4—adrenal gland—asthma	0.000201	0.00176	CbGeAlD
Bosutinib—SIK1—adrenal gland—asthma	0.000201	0.00176	CbGeAlD
Bosutinib—MAP3K12—lung—asthma	0.0002	0.00175	CbGeAlD
Bosutinib—EPHA4—adrenal gland—asthma	0.000199	0.00174	CbGeAlD
Bosutinib—SRC—smooth muscle tissue—asthma	0.000197	0.00172	CbGeAlD
Bosutinib—ULK3—adrenal gland—asthma	0.000197	0.00172	CbGeAlD
Bosutinib—MAP2K2—adrenal gland—asthma	0.000197	0.00172	CbGeAlD
Bosutinib—MAP2K1—lung—asthma	0.000196	0.00171	CbGeAlD
Bosutinib—STK35—lung—asthma	0.000196	0.00171	CbGeAlD
Bosutinib—MAP3K2—adrenal gland—asthma	0.000195	0.00171	CbGeAlD
Bosutinib—CSK—lung—asthma	0.000195	0.0017	CbGeAlD
Bosutinib—PDGFRB—respiratory system—asthma	0.000195	0.0017	CbGeAlD
Bosutinib—Gefitinib—ALB—asthma	0.000195	0.0806	CrCbGaD
Bosutinib—MAP3K7—adrenal gland—asthma	0.000194	0.00169	CbGeAlD
Bosutinib—CSNK1A1—lung—asthma	0.000193	0.00169	CbGeAlD
Bosutinib—STK10—cardiovascular system—asthma	0.000193	0.00168	CbGeAlD
Bosutinib—HCK—lung—asthma	0.000192	0.00168	CbGeAlD
Bosutinib—CLK1—lung—asthma	0.000192	0.00168	CbGeAlD
Bosutinib—TAOK3—cardiovascular system—asthma	0.000192	0.00168	CbGeAlD
Bosutinib—TBK1—adrenal gland—asthma	0.000191	0.00167	CbGeAlD
Bosutinib—PTK2—adrenal gland—asthma	0.000191	0.00167	CbGeAlD
Bosutinib—ABL2—lung—asthma	0.000191	0.00167	CbGeAlD
Bosutinib—MAP2K5—adrenal cortex—asthma	0.000189	0.00165	CbGeAlD
Bosutinib—BMP2K—lung—asthma	0.000189	0.00165	CbGeAlD
Bosutinib—CAMK2G—lung—asthma	0.000189	0.00165	CbGeAlD
Bosutinib—YES1—trachea—asthma	0.000188	0.00164	CbGeAlD
Bosutinib—IRAK1—adrenal gland—asthma	0.000188	0.00164	CbGeAlD
Bosutinib—SRC—cardiovascular system—asthma	0.000187	0.00164	CbGeAlD
Bosutinib—LRRK2—lung—asthma	0.000187	0.00163	CbGeAlD
Bosutinib—EGFR—lung—asthma	0.000186	0.00163	CbGeAlD
Bosutinib—TAOK3—trachea—asthma	0.000185	0.00162	CbGeAlD
Bosutinib—MAP2K5—bronchus—asthma	0.000185	0.00162	CbGeAlD
Bosutinib—CSF1R—adrenal cortex—asthma	0.000184	0.00161	CbGeAlD
Bosutinib—RPS6KB1—adrenal gland—asthma	0.000184	0.00161	CbGeAlD
Bosutinib—FGR—adrenal gland—asthma	0.000183	0.0016	CbGeAlD
Bosutinib—LCK—adrenal gland—asthma	0.000183	0.0016	CbGeAlD
Bosutinib—AXL—adrenal gland—asthma	0.000182	0.00159	CbGeAlD
Bosutinib—PTK2B—lung—asthma	0.000182	0.00159	CbGeAlD
Bosutinib—CSF1R—bronchus—asthma	0.000181	0.00158	CbGeAlD
Bosutinib—CSNK1E—lung—asthma	0.000179	0.00157	CbGeAlD
Bosutinib—CSF1R—smooth muscle tissue—asthma	0.000177	0.00154	CbGeAlD
Bosutinib—SIK1—lung—asthma	0.000176	0.00154	CbGeAlD
Bosutinib—IRAK4—lung—asthma	0.000176	0.00154	CbGeAlD
Bosutinib—EPHB2—Diflorasone—Fluticasone furoate—asthma	0.000175	0.0523	CbGdCrCtD
Bosutinib—SLK—adrenal gland—asthma	0.000175	0.00153	CbGeAlD
Bosutinib—EPHA4—lung—asthma	0.000175	0.00153	CbGeAlD
Bosutinib—EPHB4—adrenal gland—asthma	0.000174	0.00152	CbGeAlD
Bosutinib—ABL1—respiratory system—asthma	0.000173	0.00152	CbGeAlD
Bosutinib—ERBB3—lung—asthma	0.000173	0.00151	CbGeAlD
Bosutinib—ULK3—lung—asthma	0.000172	0.00151	CbGeAlD
Bosutinib—MAP2K2—lung—asthma	0.000172	0.00151	CbGeAlD
Bosutinib—MAP2K5—cardiovascular system—asthma	0.000172	0.0015	CbGeAlD
Bosutinib—MAP3K2—lung—asthma	0.000171	0.0015	CbGeAlD
Bosutinib—EPHA2—adrenal gland—asthma	0.000171	0.00149	CbGeAlD
Bosutinib—FYN—adrenal gland—asthma	0.000171	0.00149	CbGeAlD
Bosutinib—MAP3K7—lung—asthma	0.00017	0.00148	CbGeAlD
Bosutinib—CSF1R—cardiovascular system—asthma	0.000168	0.00147	CbGeAlD
Bosutinib—TBK1—lung—asthma	0.000168	0.00147	CbGeAlD
Bosutinib—PTK2—lung—asthma	0.000168	0.00147	CbGeAlD
Bosutinib—MAP4K5—adrenal gland—asthma	0.000167	0.00146	CbGeAlD
Bosutinib—MAP3K3—adrenal gland—asthma	0.000167	0.00146	CbGeAlD
Bosutinib—MAP2K5—trachea—asthma	0.000166	0.00145	CbGeAlD
Bosutinib—IRAK1—lung—asthma	0.000164	0.00144	CbGeAlD
Bosutinib—EPHB2—Diflorasone—Fluticasone Propionate—asthma	0.000164	0.0488	CbGdCrCtD
Bosutinib—PDGFRB—adrenal cortex—asthma	0.000163	0.00143	CbGeAlD
Bosutinib—PDGFRB—epithelium—asthma	0.000163	0.00142	CbGeAlD
Bosutinib—CSF1R—trachea—asthma	0.000162	0.00142	CbGeAlD
Bosutinib—RPS6KB1—lung—asthma	0.000161	0.00141	CbGeAlD
Bosutinib—LCK—lung—asthma	0.00016	0.0014	CbGeAlD
Bosutinib—FGR—lung—asthma	0.00016	0.0014	CbGeAlD
Bosutinib—PDGFRB—bronchus—asthma	0.00016	0.0014	CbGeAlD
Bosutinib—AXL—lung—asthma	0.00016	0.0014	CbGeAlD
Bosutinib—PDGFRB—smooth muscle tissue—asthma	0.000157	0.00137	CbGeAlD
Bosutinib—YES1—adrenal gland—asthma	0.000154	0.00134	CbGeAlD
Bosutinib—SLK—lung—asthma	0.000154	0.00134	CbGeAlD
Bosutinib—EPHB4—lung—asthma	0.000153	0.00133	CbGeAlD
Bosutinib—STK10—adrenal gland—asthma	0.000152	0.00133	CbGeAlD
Bosutinib—TAOK3—adrenal gland—asthma	0.000152	0.00133	CbGeAlD
Bosutinib—EPHA2—lung—asthma	0.00015	0.00131	CbGeAlD
Bosutinib—FYN—lung—asthma	0.000149	0.00131	CbGeAlD
Bosutinib—PDGFRB—cardiovascular system—asthma	0.000149	0.0013	CbGeAlD
Bosutinib—SRC—adrenal gland—asthma	0.000148	0.00129	CbGeAlD
Bosutinib—MAP3K3—lung—asthma	0.000146	0.00128	CbGeAlD
Bosutinib—MAP4K5—lung—asthma	0.000146	0.00128	CbGeAlD
Bosutinib—ABL1—adrenal cortex—asthma	0.000146	0.00127	CbGeAlD
Bosutinib—PDGFRB—trachea—asthma	0.000144	0.00126	CbGeAlD
Bosutinib—ABL1—bronchus—asthma	0.000143	0.00125	CbGeAlD
Bosutinib—ABL1—smooth muscle tissue—asthma	0.00014	0.00122	CbGeAlD
Bosutinib—PTK2B—Pindolol—Isoprenaline—asthma	0.000138	0.0411	CbGdCrCtD
Bosutinib—MAP2K5—adrenal gland—asthma	0.000136	0.00119	CbGeAlD
Bosutinib—YES1—lung—asthma	0.000135	0.00118	CbGeAlD
Bosutinib—STK10—lung—asthma	0.000134	0.00117	CbGeAlD
Bosutinib—TAOK3—lung—asthma	0.000133	0.00116	CbGeAlD
Bosutinib—CSF1R—adrenal gland—asthma	0.000133	0.00116	CbGeAlD
Bosutinib—ABL1—cardiovascular system—asthma	0.000133	0.00116	CbGeAlD
Bosutinib—SRC—lung—asthma	0.00013	0.00113	CbGeAlD
Bosutinib—ABL1—trachea—asthma	0.000128	0.00112	CbGeAlD
Bosutinib—ERBB3—Methyldopa—Isoetarine—asthma	0.000124	0.037	CbGdCrCtD
Bosutinib—EPHB2—Diflorasone—Beclomethasone—asthma	0.00012	0.0359	CbGdCrCtD
Bosutinib—MAP2K5—lung—asthma	0.000119	0.00104	CbGeAlD
Bosutinib—PDGFRB—adrenal gland—asthma	0.000118	0.00103	CbGeAlD
Bosutinib—CSF1R—lung—asthma	0.000116	0.00102	CbGeAlD
Bosutinib—EPHB2—Diflorasone—Budesonide—asthma	0.000115	0.0344	CbGdCrCtD
Bosutinib—EPHB2—Diflorasone—Flunisolide—asthma	0.000114	0.0339	CbGdCrCtD
Bosutinib—ABL1—adrenal gland—asthma	0.000105	0.000918	CbGeAlD
Bosutinib—PDGFRB—lung—asthma	0.000103	0.000903	CbGeAlD
Bosutinib—ERBB3—Methyldopa—Isoprenaline—asthma	9.41e-05	0.0281	CbGdCrCtD
Bosutinib—EPHB2—Diflorasone—Mometasone—asthma	9.32e-05	0.0278	CbGdCrCtD
Bosutinib—ABL1—lung—asthma	9.21e-05	0.000805	CbGeAlD
Bosutinib—PLK2—Levonorgestrel—Hydrocortisone—asthma	7.28e-05	0.0217	CbGdCrCtD
Bosutinib—MAP4K4—Testosterone Propionate—Hydrocortisone—asthma	7.01e-05	0.0209	CbGdCrCtD
Bosutinib—Nausea—Tiotropium—asthma	6.7e-05	0.000457	CcSEcCtD
Bosutinib—Connective tissue disorder—Hydrocortisone—asthma	6.66e-05	0.000455	CcSEcCtD
Bosutinib—Vomiting—Flunisolide—asthma	6.64e-05	0.000454	CcSEcCtD
Bosutinib—Diarrhoea—Mometasone—asthma	6.63e-05	0.000453	CcSEcCtD
Bosutinib—Urticaria—Budesonide—asthma	6.61e-05	0.000451	CcSEcCtD
Bosutinib—Rash—Flunisolide—asthma	6.59e-05	0.00045	CcSEcCtD
Bosutinib—Dermatitis—Flunisolide—asthma	6.58e-05	0.000449	CcSEcCtD
Bosutinib—Abdominal pain—Budesonide—asthma	6.58e-05	0.000449	CcSEcCtD
Bosutinib—Body temperature increased—Budesonide—asthma	6.58e-05	0.000449	CcSEcCtD
Bosutinib—Headache—Flunisolide—asthma	6.55e-05	0.000447	CcSEcCtD
Bosutinib—Asthenia—Formoterol—asthma	6.53e-05	0.000446	CcSEcCtD
Bosutinib—Asthenia—Arformoterol—asthma	6.53e-05	0.000446	CcSEcCtD
Bosutinib—Pruritus—Arformoterol—asthma	6.44e-05	0.00044	CcSEcCtD
Bosutinib—Pruritus—Formoterol—asthma	6.44e-05	0.00044	CcSEcCtD
Bosutinib—Alanine aminotransferase increased—Prednisone—asthma	6.43e-05	0.000439	CcSEcCtD
Bosutinib—Asthenia—Montelukast—asthma	6.39e-05	0.000437	CcSEcCtD
Bosutinib—Pruritus—Montelukast—asthma	6.3e-05	0.000431	CcSEcCtD
Bosutinib—Connective tissue disorder—Methylprednisolone—asthma	6.25e-05	0.000427	CcSEcCtD
Bosutinib—Diarrhoea—Formoterol—asthma	6.23e-05	0.000425	CcSEcCtD
Bosutinib—Diarrhoea—Arformoterol—asthma	6.23e-05	0.000425	CcSEcCtD
Bosutinib—Nausea—Flunisolide—asthma	6.21e-05	0.000424	CcSEcCtD
Bosutinib—Asthenia—Salbutamol—asthma	6.16e-05	0.000421	CcSEcCtD
Bosutinib—Vomiting—Mometasone—asthma	6.16e-05	0.000421	CcSEcCtD
Bosutinib—Immune system disorder—Hydrocortisone—asthma	6.12e-05	0.000418	CcSEcCtD
Bosutinib—Rash—Mometasone—asthma	6.11e-05	0.000417	CcSEcCtD
Bosutinib—Dermatitis—Mometasone—asthma	6.11e-05	0.000417	CcSEcCtD
Bosutinib—Diarrhoea—Montelukast—asthma	6.1e-05	0.000416	CcSEcCtD
Bosutinib—Pruritus—Salbutamol—asthma	6.08e-05	0.000415	CcSEcCtD
Bosutinib—Headache—Mometasone—asthma	6.07e-05	0.000415	CcSEcCtD
Bosutinib—CSNK1E—Betamethasone—Fluticasone furoate—asthma	6.06e-05	0.0181	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Fluticasone furoate—asthma	6.06e-05	0.0181	CbGdCrCtD
Bosutinib—Dizziness—Arformoterol—asthma	6.02e-05	0.000411	CcSEcCtD
Bosutinib—Dizziness—Formoterol—asthma	6.02e-05	0.000411	CcSEcCtD
Bosutinib—Asthenia—Budesonide—asthma	5.97e-05	0.000408	CcSEcCtD
Bosutinib—Cardiac disorder—Methylprednisolone—asthma	5.91e-05	0.000403	CcSEcCtD
Bosutinib—Malnutrition—Hydrocortisone—asthma	5.9e-05	0.000403	CcSEcCtD
Bosutinib—Dizziness—Montelukast—asthma	5.89e-05	0.000402	CcSEcCtD
Bosutinib—Neutropenia—Prednisone—asthma	5.89e-05	0.000402	CcSEcCtD
Bosutinib—Pruritus—Budesonide—asthma	5.89e-05	0.000402	CcSEcCtD
Bosutinib—Diarrhoea—Salbutamol—asthma	5.88e-05	0.000401	CcSEcCtD
Bosutinib—Vomiting—Formoterol—asthma	5.78e-05	0.000395	CcSEcCtD
Bosutinib—Vomiting—Arformoterol—asthma	5.78e-05	0.000395	CcSEcCtD
Bosutinib—Nausea—Mometasone—asthma	5.76e-05	0.000393	CcSEcCtD
Bosutinib—Immune system disorder—Methylprednisolone—asthma	5.75e-05	0.000393	CcSEcCtD
Bosutinib—Rash—Formoterol—asthma	5.74e-05	0.000392	CcSEcCtD
Bosutinib—Rash—Arformoterol—asthma	5.74e-05	0.000392	CcSEcCtD
Bosutinib—Mediastinal disorder—Methylprednisolone—asthma	5.74e-05	0.000392	CcSEcCtD
Bosutinib—Dermatitis—Formoterol—asthma	5.73e-05	0.000391	CcSEcCtD
Bosutinib—Dermatitis—Arformoterol—asthma	5.73e-05	0.000391	CcSEcCtD
Bosutinib—Headache—Arformoterol—asthma	5.7e-05	0.000389	CcSEcCtD
Bosutinib—Headache—Formoterol—asthma	5.7e-05	0.000389	CcSEcCtD
Bosutinib—Diarrhoea—Budesonide—asthma	5.69e-05	0.000389	CcSEcCtD
Bosutinib—Dizziness—Salbutamol—asthma	5.68e-05	0.000388	CcSEcCtD
Bosutinib—Vomiting—Montelukast—asthma	5.67e-05	0.000387	CcSEcCtD
Bosutinib—CSNK1E—Betamethasone—Fluticasone Propionate—asthma	5.65e-05	0.0169	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Fluticasone Propionate—asthma	5.65e-05	0.0169	CbGdCrCtD
Bosutinib—Rash—Montelukast—asthma	5.62e-05	0.000384	CcSEcCtD
Bosutinib—Dermatitis—Montelukast—asthma	5.61e-05	0.000383	CcSEcCtD
Bosutinib—Ill-defined disorder—Prednisolone—asthma	5.6e-05	0.000383	CcSEcCtD
Bosutinib—Headache—Montelukast—asthma	5.58e-05	0.000381	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Methylprednisolone—asthma	5.57e-05	0.0166	CbGdCrCtD
Bosutinib—Malnutrition—Methylprednisolone—asthma	5.54e-05	0.000378	CcSEcCtD
Bosutinib—Dizziness—Budesonide—asthma	5.5e-05	0.000376	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Dexamethasone—asthma	5.48e-05	0.0163	CbGdCrCtD
Bosutinib—EPHB2—Diflorasone—Betamethasone—asthma	5.48e-05	0.0163	CbGdCrCtD
Bosutinib—Ill-defined disorder—Hydrocortisone—asthma	5.47e-05	0.000374	CcSEcCtD
Bosutinib—Vomiting—Salbutamol—asthma	5.46e-05	0.000373	CcSEcCtD
Bosutinib—Malaise—Prednisolone—asthma	5.44e-05	0.000372	CcSEcCtD
Bosutinib—Dysgeusia—Triamcinolone—asthma	5.44e-05	0.000371	CcSEcCtD
Bosutinib—Rash—Salbutamol—asthma	5.42e-05	0.00037	CcSEcCtD
Bosutinib—Dermatitis—Salbutamol—asthma	5.41e-05	0.00037	CcSEcCtD
Bosutinib—Nausea—Formoterol—asthma	5.4e-05	0.000369	CcSEcCtD
Bosutinib—Nausea—Arformoterol—asthma	5.4e-05	0.000369	CcSEcCtD
Bosutinib—ABCB1—respiratory system—asthma	5.39e-05	0.000471	CbGeAlD
Bosutinib—Headache—Salbutamol—asthma	5.38e-05	0.000368	CcSEcCtD
Bosutinib—Back pain—Triamcinolone—asthma	5.37e-05	0.000367	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Triamcinolone—asthma	5.35e-05	0.016	CbGdCrCtD
Bosutinib—Malaise—Hydrocortisone—asthma	5.32e-05	0.000363	CcSEcCtD
Bosutinib—Nausea—Montelukast—asthma	5.29e-05	0.000361	CcSEcCtD
Bosutinib—Vomiting—Budesonide—asthma	5.29e-05	0.000361	CcSEcCtD
Bosutinib—Rash—Budesonide—asthma	5.25e-05	0.000358	CcSEcCtD
Bosutinib—Dermatitis—Budesonide—asthma	5.24e-05	0.000358	CcSEcCtD
Bosutinib—Headache—Budesonide—asthma	5.21e-05	0.000356	CcSEcCtD
Bosutinib—Ill-defined disorder—Triamcinolone—asthma	5.15e-05	0.000352	CcSEcCtD
Bosutinib—Ill-defined disorder—Methylprednisolone—asthma	5.14e-05	0.000351	CcSEcCtD
Bosutinib—Nausea—Salbutamol—asthma	5.1e-05	0.000348	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Prednisone—asthma	5.08e-05	0.0152	CbGdCrCtD
Bosutinib—Discomfort—Prednisolone—asthma	5.08e-05	0.000347	CcSEcCtD
Bosutinib—Myalgia—Hydrocortisone—asthma	5.02e-05	0.000343	CcSEcCtD
Bosutinib—Malaise—Triamcinolone—asthma	5.01e-05	0.000342	CcSEcCtD
Bosutinib—Malaise—Methylprednisolone—asthma	5e-05	0.000341	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	4.99e-05	0.00034	CcSEcCtD
Bosutinib—Discomfort—Hydrocortisone—asthma	4.96e-05	0.000339	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Prednisolone—asthma	4.96e-05	0.0148	CbGdCrCtD
Bosutinib—Connective tissue disorder—Prednisone—asthma	4.95e-05	0.000338	CcSEcCtD
Bosutinib—Nausea—Budesonide—asthma	4.94e-05	0.000338	CcSEcCtD
Bosutinib—Oedema—Prednisolone—asthma	4.93e-05	0.000336	CcSEcCtD
Bosutinib—Anaphylactic shock—Prednisolone—asthma	4.93e-05	0.000336	CcSEcCtD
Bosutinib—Cough—Triamcinolone—asthma	4.84e-05	0.000331	CcSEcCtD
Bosutinib—Oedema—Hydrocortisone—asthma	4.81e-05	0.000329	CcSEcCtD
Bosutinib—Anaphylactic shock—Hydrocortisone—asthma	4.81e-05	0.000329	CcSEcCtD
Bosutinib—Infection—Hydrocortisone—asthma	4.78e-05	0.000326	CcSEcCtD
Bosutinib—Myalgia—Triamcinolone—asthma	4.73e-05	0.000323	CcSEcCtD
Bosutinib—Nervous system disorder—Hydrocortisone—asthma	4.72e-05	0.000322	CcSEcCtD
Bosutinib—Myalgia—Methylprednisolone—asthma	4.72e-05	0.000322	CcSEcCtD
Bosutinib—Arthralgia—Methylprednisolone—asthma	4.72e-05	0.000322	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	4.68e-05	0.00032	CcSEcCtD
Bosutinib—Skin disorder—Hydrocortisone—asthma	4.67e-05	0.000319	CcSEcCtD
Bosutinib—Ill-defined disorder—Betamethasone—asthma	4.67e-05	0.000319	CcSEcCtD
Bosutinib—Ill-defined disorder—Dexamethasone—asthma	4.67e-05	0.000319	CcSEcCtD
Bosutinib—Discomfort—Triamcinolone—asthma	4.67e-05	0.000319	CcSEcCtD
Bosutinib—Discomfort—Methylprednisolone—asthma	4.66e-05	0.000318	CcSEcCtD
Bosutinib—Immune system disorder—Prednisone—asthma	4.55e-05	0.000311	CcSEcCtD
Bosutinib—Malaise—Betamethasone—asthma	4.54e-05	0.00031	CcSEcCtD
Bosutinib—Malaise—Dexamethasone—asthma	4.54e-05	0.00031	CcSEcCtD
Bosutinib—Anaphylactic shock—Triamcinolone—asthma	4.53e-05	0.000309	CcSEcCtD
Bosutinib—Oedema—Triamcinolone—asthma	4.53e-05	0.000309	CcSEcCtD
Bosutinib—ABCB1—adrenal cortex—asthma	4.53e-05	0.000395	CbGeAlD
Bosutinib—Anaphylactic shock—Methylprednisolone—asthma	4.52e-05	0.000309	CcSEcCtD
Bosutinib—ABCB1—epithelium—asthma	4.51e-05	0.000394	CbGeAlD
Bosutinib—Infection—Triamcinolone—asthma	4.5e-05	0.000307	CcSEcCtD
Bosutinib—Infection—Methylprednisolone—asthma	4.49e-05	0.000307	CcSEcCtD
Bosutinib—Nervous system disorder—Methylprednisolone—asthma	4.43e-05	0.000303	CcSEcCtD
Bosutinib—Skin disorder—Methylprednisolone—asthma	4.39e-05	0.0003	CcSEcCtD
Bosutinib—Malnutrition—Prednisone—asthma	4.39e-05	0.0003	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Hydrocortisone—asthma	4.38e-05	0.000299	CcSEcCtD
Bosutinib—Myalgia—Dexamethasone—asthma	4.29e-05	0.000293	CcSEcCtD
Bosutinib—Myalgia—Betamethasone—asthma	4.29e-05	0.000293	CcSEcCtD
Bosutinib—Discomfort—Dexamethasone—asthma	4.24e-05	0.000289	CcSEcCtD
Bosutinib—Discomfort—Betamethasone—asthma	4.24e-05	0.000289	CcSEcCtD
Bosutinib—Pain—Prednisolone—asthma	4.21e-05	0.000288	CcSEcCtD
Bosutinib—Decreased appetite—Hydrocortisone—asthma	4.18e-05	0.000286	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Hydrocortisone—asthma	4.15e-05	0.000284	CcSEcCtD
Bosutinib—CSNK1E—Dexamethasone—Beclomethasone—asthma	4.15e-05	0.0124	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Beclomethasone—asthma	4.15e-05	0.0124	CbGdCrCtD
Bosutinib—Fatigue—Hydrocortisone—asthma	4.15e-05	0.000283	CcSEcCtD
Bosutinib—ABCB1—cardiovascular system—asthma	4.13e-05	0.000361	CbGeAlD
Bosutinib—Musculoskeletal discomfort—Triamcinolone—asthma	4.13e-05	0.000282	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Methylprednisolone—asthma	4.12e-05	0.000281	CcSEcCtD
Bosutinib—Pain—Hydrocortisone—asthma	4.12e-05	0.000281	CcSEcCtD
Bosutinib—Oedema—Betamethasone—asthma	4.11e-05	0.000281	CcSEcCtD
Bosutinib—Anaphylactic shock—Betamethasone—asthma	4.11e-05	0.000281	CcSEcCtD
Bosutinib—Anaphylactic shock—Dexamethasone—asthma	4.11e-05	0.000281	CcSEcCtD
Bosutinib—Oedema—Dexamethasone—asthma	4.11e-05	0.000281	CcSEcCtD
Bosutinib—Infection—Dexamethasone—asthma	4.08e-05	0.000279	CcSEcCtD
Bosutinib—Infection—Betamethasone—asthma	4.08e-05	0.000279	CcSEcCtD
Bosutinib—Ill-defined disorder—Prednisone—asthma	4.07e-05	0.000278	CcSEcCtD
Bosutinib—Feeling abnormal—Prednisolone—asthma	4.06e-05	0.000277	CcSEcCtD
Bosutinib—Anaemia—Prednisone—asthma	4.05e-05	0.000277	CcSEcCtD
Bosutinib—Dyspnoea—Triamcinolone—asthma	4.04e-05	0.000276	CcSEcCtD
Bosutinib—Nervous system disorder—Betamethasone—asthma	4.03e-05	0.000275	CcSEcCtD
Bosutinib—Nervous system disorder—Dexamethasone—asthma	4.03e-05	0.000275	CcSEcCtD
Bosutinib—Thrombocytopenia—Dexamethasone—asthma	4.03e-05	0.000275	CcSEcCtD
Bosutinib—Thrombocytopenia—Betamethasone—asthma	4.03e-05	0.000275	CcSEcCtD
Bosutinib—ABCB1—trachea—asthma	3.99e-05	0.000348	CbGeAlD
Bosutinib—CSNK1E—Dexamethasone—Budesonide—asthma	3.98e-05	0.0119	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Budesonide—asthma	3.98e-05	0.0119	CbGdCrCtD
Bosutinib—Feeling abnormal—Hydrocortisone—asthma	3.97e-05	0.000271	CcSEcCtD
Bosutinib—Malaise—Prednisone—asthma	3.96e-05	0.00027	CcSEcCtD
Bosutinib—Gastrointestinal pain—Hydrocortisone—asthma	3.94e-05	0.000269	CcSEcCtD
Bosutinib—CSNK1E—Dexamethasone—Flunisolide—asthma	3.93e-05	0.0117	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Flunisolide—asthma	3.93e-05	0.0117	CbGdCrCtD
Bosutinib—Urticaria—Prednisolone—asthma	3.91e-05	0.000267	CcSEcCtD
Bosutinib—Fatigue—Triamcinolone—asthma	3.91e-05	0.000267	CcSEcCtD
Bosutinib—Fatigue—Methylprednisolone—asthma	3.9e-05	0.000266	CcSEcCtD
Bosutinib—Pain—Triamcinolone—asthma	3.87e-05	0.000265	CcSEcCtD
Bosutinib—Urticaria—Hydrocortisone—asthma	3.82e-05	0.000261	CcSEcCtD
Bosutinib—Abdominal pain—Hydrocortisone—asthma	3.8e-05	0.00026	CcSEcCtD
Bosutinib—Body temperature increased—Hydrocortisone—asthma	3.8e-05	0.00026	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Dexamethasone—asthma	3.75e-05	0.000256	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Betamethasone—asthma	3.75e-05	0.000256	CcSEcCtD
Bosutinib—Arthralgia—Prednisone—asthma	3.74e-05	0.000255	CcSEcCtD
Bosutinib—Myalgia—Prednisone—asthma	3.74e-05	0.000255	CcSEcCtD
Bosutinib—Feeling abnormal—Triamcinolone—asthma	3.73e-05	0.000255	CcSEcCtD
Bosutinib—Feeling abnormal—Methylprednisolone—asthma	3.73e-05	0.000254	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.71e-05	0.000253	CcSEcCtD
Bosutinib—Gastrointestinal pain—Methylprednisolone—asthma	3.7e-05	0.000252	CcSEcCtD
Bosutinib—Discomfort—Prednisone—asthma	3.69e-05	0.000252	CcSEcCtD
Bosutinib—Urticaria—Triamcinolone—asthma	3.6e-05	0.000246	CcSEcCtD
Bosutinib—Urticaria—Methylprednisolone—asthma	3.59e-05	0.000245	CcSEcCtD
Bosutinib—Body temperature increased—Triamcinolone—asthma	3.58e-05	0.000245	CcSEcCtD
Bosutinib—Anaphylactic shock—Prednisone—asthma	3.58e-05	0.000245	CcSEcCtD
Bosutinib—Oedema—Prednisone—asthma	3.58e-05	0.000245	CcSEcCtD
Bosutinib—Abdominal pain—Methylprednisolone—asthma	3.57e-05	0.000244	CcSEcCtD
Bosutinib—Decreased appetite—Dexamethasone—asthma	3.57e-05	0.000244	CcSEcCtD
Bosutinib—Decreased appetite—Betamethasone—asthma	3.57e-05	0.000244	CcSEcCtD
Bosutinib—Infection—Prednisone—asthma	3.56e-05	0.000243	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Dexamethasone—asthma	3.55e-05	0.000242	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Betamethasone—asthma	3.55e-05	0.000242	CcSEcCtD
Bosutinib—Fatigue—Betamethasone—asthma	3.54e-05	0.000242	CcSEcCtD
Bosutinib—Fatigue—Dexamethasone—asthma	3.54e-05	0.000242	CcSEcCtD
Bosutinib—Pain—Dexamethasone—asthma	3.52e-05	0.00024	CcSEcCtD
Bosutinib—Pain—Betamethasone—asthma	3.52e-05	0.00024	CcSEcCtD
Bosutinib—Nervous system disorder—Prednisone—asthma	3.51e-05	0.00024	CcSEcCtD
Bosutinib—Skin disorder—Prednisone—asthma	3.48e-05	0.000238	CcSEcCtD
Bosutinib—Asthenia—Hydrocortisone—asthma	3.45e-05	0.000236	CcSEcCtD
Bosutinib—Pruritus—Hydrocortisone—asthma	3.4e-05	0.000233	CcSEcCtD
Bosutinib—Feeling abnormal—Dexamethasone—asthma	3.39e-05	0.000231	CcSEcCtD
Bosutinib—Feeling abnormal—Betamethasone—asthma	3.39e-05	0.000231	CcSEcCtD
Bosutinib—Gastrointestinal pain—Betamethasone—asthma	3.36e-05	0.00023	CcSEcCtD
Bosutinib—Gastrointestinal pain—Dexamethasone—asthma	3.36e-05	0.00023	CcSEcCtD
Bosutinib—PKMYT1—Danazol—Hydrocortisone—asthma	3.35e-05	0.00999	CbGdCrCtD
Bosutinib—Diarrhoea—Hydrocortisone—asthma	3.29e-05	0.000225	CcSEcCtD
Bosutinib—ABCB1—adrenal gland—asthma	3.27e-05	0.000285	CbGeAlD
Bosutinib—Urticaria—Betamethasone—asthma	3.27e-05	0.000223	CcSEcCtD
Bosutinib—Urticaria—Dexamethasone—asthma	3.27e-05	0.000223	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Prednisone—asthma	3.26e-05	0.000223	CcSEcCtD
Bosutinib—Dizziness—Prednisolone—asthma	3.26e-05	0.000223	CcSEcCtD
Bosutinib—Asthenia—Triamcinolone—asthma	3.25e-05	0.000222	CcSEcCtD
Bosutinib—Abdominal pain—Dexamethasone—asthma	3.25e-05	0.000222	CcSEcCtD
Bosutinib—Abdominal pain—Betamethasone—asthma	3.25e-05	0.000222	CcSEcCtD
Bosutinib—Body temperature increased—Betamethasone—asthma	3.25e-05	0.000222	CcSEcCtD
Bosutinib—Body temperature increased—Dexamethasone—asthma	3.25e-05	0.000222	CcSEcCtD
Bosutinib—Asthenia—Methylprednisolone—asthma	3.24e-05	0.000222	CcSEcCtD
Bosutinib—CSNK1E—Dexamethasone—Mometasone—asthma	3.22e-05	0.00961	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Mometasone—asthma	3.22e-05	0.00961	CbGdCrCtD
Bosutinib—Pruritus—Triamcinolone—asthma	3.21e-05	0.000219	CcSEcCtD
Bosutinib—Pruritus—Methylprednisolone—asthma	3.2e-05	0.000218	CcSEcCtD
Bosutinib—CSNK1E—Danazol—Hydrocortisone—asthma	3.19e-05	0.00953	CbGdCrCtD
Bosutinib—Dizziness—Hydrocortisone—asthma	3.18e-05	0.000217	CcSEcCtD
Bosutinib—Decreased appetite—Prednisone—asthma	3.11e-05	0.000213	CcSEcCtD
Bosutinib—Rash—Prednisolone—asthma	3.11e-05	0.000212	CcSEcCtD
Bosutinib—Dermatitis—Prednisolone—asthma	3.1e-05	0.000212	CcSEcCtD
Bosutinib—Diarrhoea—Methylprednisolone—asthma	3.09e-05	0.000211	CcSEcCtD
Bosutinib—Fatigue—Prednisone—asthma	3.09e-05	0.000211	CcSEcCtD
Bosutinib—Headache—Prednisolone—asthma	3.09e-05	0.000211	CcSEcCtD
Bosutinib—Vomiting—Hydrocortisone—asthma	3.06e-05	0.000209	CcSEcCtD
Bosutinib—Rash—Hydrocortisone—asthma	3.03e-05	0.000207	CcSEcCtD
Bosutinib—Dermatitis—Hydrocortisone—asthma	3.03e-05	0.000207	CcSEcCtD
Bosutinib—Headache—Hydrocortisone—asthma	3.01e-05	0.000206	CcSEcCtD
Bosutinib—Dizziness—Triamcinolone—asthma	3e-05	0.000205	CcSEcCtD
Bosutinib—Dizziness—Methylprednisolone—asthma	2.99e-05	0.000204	CcSEcCtD
Bosutinib—Feeling abnormal—Prednisone—asthma	2.95e-05	0.000201	CcSEcCtD
Bosutinib—Asthenia—Betamethasone—asthma	2.95e-05	0.000201	CcSEcCtD
Bosutinib—Asthenia—Dexamethasone—asthma	2.95e-05	0.000201	CcSEcCtD
Bosutinib—Gastrointestinal pain—Prednisone—asthma	2.93e-05	0.0002	CcSEcCtD
Bosutinib—Nausea—Prednisolone—asthma	2.93e-05	0.0002	CcSEcCtD
Bosutinib—Pruritus—Betamethasone—asthma	2.91e-05	0.000199	CcSEcCtD
Bosutinib—Pruritus—Dexamethasone—asthma	2.91e-05	0.000199	CcSEcCtD
Bosutinib—PKMYT1—Danazol—Prednisone—asthma	2.88e-05	0.0086	CbGdCrCtD
Bosutinib—Vomiting—Triamcinolone—asthma	2.88e-05	0.000197	CcSEcCtD
Bosutinib—Vomiting—Methylprednisolone—asthma	2.87e-05	0.000196	CcSEcCtD
Bosutinib—ABCB1—lung—asthma	2.86e-05	0.00025	CbGeAlD
Bosutinib—Nausea—Hydrocortisone—asthma	2.86e-05	0.000195	CcSEcCtD
Bosutinib—Rash—Triamcinolone—asthma	2.86e-05	0.000195	CcSEcCtD
Bosutinib—Dermatitis—Triamcinolone—asthma	2.85e-05	0.000195	CcSEcCtD
Bosutinib—Rash—Methylprednisolone—asthma	2.85e-05	0.000195	CcSEcCtD
Bosutinib—Dermatitis—Methylprednisolone—asthma	2.85e-05	0.000194	CcSEcCtD
Bosutinib—Urticaria—Prednisone—asthma	2.84e-05	0.000194	CcSEcCtD
Bosutinib—Headache—Triamcinolone—asthma	2.84e-05	0.000194	CcSEcCtD
Bosutinib—Headache—Methylprednisolone—asthma	2.83e-05	0.000193	CcSEcCtD
Bosutinib—Abdominal pain—Prednisone—asthma	2.83e-05	0.000193	CcSEcCtD
Bosutinib—Body temperature increased—Prednisone—asthma	2.83e-05	0.000193	CcSEcCtD
Bosutinib—Diarrhoea—Dexamethasone—asthma	2.81e-05	0.000192	CcSEcCtD
Bosutinib—Diarrhoea—Betamethasone—asthma	2.81e-05	0.000192	CcSEcCtD
Bosutinib—CSNK1E—Danazol—Prednisone—asthma	2.75e-05	0.0082	CbGdCrCtD
Bosutinib—Dizziness—Dexamethasone—asthma	2.72e-05	0.000186	CcSEcCtD
Bosutinib—Dizziness—Betamethasone—asthma	2.72e-05	0.000186	CcSEcCtD
Bosutinib—Nausea—Triamcinolone—asthma	2.69e-05	0.000184	CcSEcCtD
Bosutinib—Nausea—Methylprednisolone—asthma	2.69e-05	0.000183	CcSEcCtD
Bosutinib—Vomiting—Betamethasone—asthma	2.61e-05	0.000179	CcSEcCtD
Bosutinib—Vomiting—Dexamethasone—asthma	2.61e-05	0.000179	CcSEcCtD
Bosutinib—Rash—Dexamethasone—asthma	2.59e-05	0.000177	CcSEcCtD
Bosutinib—Rash—Betamethasone—asthma	2.59e-05	0.000177	CcSEcCtD
Bosutinib—Dermatitis—Betamethasone—asthma	2.59e-05	0.000177	CcSEcCtD
Bosutinib—Dermatitis—Dexamethasone—asthma	2.59e-05	0.000177	CcSEcCtD
Bosutinib—Headache—Dexamethasone—asthma	2.58e-05	0.000176	CcSEcCtD
Bosutinib—Headache—Betamethasone—asthma	2.58e-05	0.000176	CcSEcCtD
Bosutinib—Asthenia—Prednisone—asthma	2.57e-05	0.000175	CcSEcCtD
Bosutinib—Pruritus—Prednisone—asthma	2.53e-05	0.000173	CcSEcCtD
Bosutinib—Diarrhoea—Prednisone—asthma	2.45e-05	0.000167	CcSEcCtD
Bosutinib—Nausea—Dexamethasone—asthma	2.44e-05	0.000167	CcSEcCtD
Bosutinib—Nausea—Betamethasone—asthma	2.44e-05	0.000167	CcSEcCtD
Bosutinib—Dizziness—Prednisone—asthma	2.37e-05	0.000162	CcSEcCtD
Bosutinib—Vomiting—Prednisone—asthma	2.28e-05	0.000155	CcSEcCtD
Bosutinib—Rash—Prednisone—asthma	2.26e-05	0.000154	CcSEcCtD
Bosutinib—Dermatitis—Prednisone—asthma	2.26e-05	0.000154	CcSEcCtD
Bosutinib—Headache—Prednisone—asthma	2.24e-05	0.000153	CcSEcCtD
Bosutinib—Nausea—Prednisone—asthma	2.13e-05	0.000145	CcSEcCtD
Bosutinib—CSNK1E—Betamethasone—Hydrocortisone—asthma	2.04e-05	0.00608	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Hydrocortisone—asthma	2.04e-05	0.00608	CbGdCrCtD
Bosutinib—CHEK2—Testosterone Propionate—Hydrocortisone—asthma	1.97e-05	0.00587	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Methylprednisolone—asthma	1.92e-05	0.00574	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Methylprednisolone—asthma	1.92e-05	0.00574	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Dexamethasone—asthma	1.89e-05	0.00565	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Betamethasone—asthma	1.89e-05	0.00565	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Triamcinolone—asthma	1.85e-05	0.00552	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Triamcinolone—asthma	1.85e-05	0.00552	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Prednisone—asthma	1.76e-05	0.00524	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Prednisone—asthma	1.76e-05	0.00524	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Prednisolone—asthma	1.71e-05	0.00511	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Prednisolone—asthma	1.71e-05	0.00511	CbGdCrCtD
Bosutinib—CHEK2—Danazol—Hydrocortisone—asthma	1.63e-05	0.00488	CbGdCrCtD
Bosutinib—CHEK2—Norethindrone—Hydrocortisone—asthma	1.47e-05	0.00439	CbGdCrCtD
Bosutinib—CHEK2—Danazol—Prednisone—asthma	1.41e-05	0.0042	CbGdCrCtD
Bosutinib—CHEK2—Levonorgestrel—Hydrocortisone—asthma	1.17e-05	0.0035	CbGdCrCtD
Bosutinib—ROCK1—Signaling Pathways—EGFR—asthma	7.15e-07	3.98e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—STAT3—asthma	7.15e-07	3.98e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCR5—asthma	7.14e-07	3.98e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ADCY2—asthma	7.13e-07	3.97e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CXCL8—asthma	7.12e-07	3.97e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—RHOA—asthma	7.09e-07	3.95e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—EGFR—asthma	7.04e-07	3.92e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—PTEN—asthma	7.03e-07	3.92e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL2RA—asthma	7.03e-07	3.92e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TGFB1—asthma	7.03e-07	3.91e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TGFB1—asthma	7.03e-07	3.91e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL6—asthma	7.03e-07	3.91e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SERPINE1—asthma	7.02e-07	3.91e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—RHOA—asthma	7.02e-07	3.91e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NOS3—asthma	7.02e-07	3.91e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—STAT3—asthma	6.98e-07	3.89e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—C3—asthma	6.97e-07	3.89e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CHAT—asthma	6.97e-07	3.88e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—NOS3—asthma	6.95e-07	3.87e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD4—asthma	6.93e-07	3.86e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL6—asthma	6.93e-07	3.86e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—RHOA—asthma	6.92e-07	3.85e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—FN1—asthma	6.92e-07	3.85e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SERPINE1—asthma	6.91e-07	3.85e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—EGFR—asthma	6.89e-07	3.84e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—EGFR—asthma	6.89e-07	3.84e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SERPINE1—asthma	6.88e-07	3.83e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—EGFR—asthma	6.87e-07	3.83e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NOS3—asthma	6.85e-07	3.81e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MMP9—asthma	6.84e-07	3.81e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL2—asthma	6.81e-07	3.79e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—PTEN—asthma	6.8e-07	3.79e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PDGFB—asthma	6.79e-07	3.78e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—PTEN—asthma	6.78e-07	3.78e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—RHOA—asthma	6.77e-07	3.77e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TGFB1—asthma	6.77e-07	3.77e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—STAT3—asthma	6.72e-07	3.75e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—EGFR—asthma	6.72e-07	3.74e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NOS3—asthma	6.7e-07	3.73e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL6—asthma	6.7e-07	3.73e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—EGFR—asthma	6.69e-07	3.73e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—STAT3—asthma	6.69e-07	3.73e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—RHOA—asthma	6.67e-07	3.71e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—EGFR—asthma	6.64e-07	3.7e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—RHOA—asthma	6.63e-07	3.7e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TGFB1—asthma	6.63e-07	3.69e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—EGFR—asthma	6.62e-07	3.69e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NOS3—asthma	6.6e-07	3.68e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—EGFR—asthma	6.58e-07	3.67e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL6—asthma	6.57e-07	3.66e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—VEGFA—asthma	6.57e-07	3.66e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NOS3—asthma	6.56e-07	3.66e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—POMC—asthma	6.54e-07	3.64e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—STAT3—asthma	6.5e-07	3.62e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—EGFR—asthma	6.5e-07	3.62e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—PTEN—asthma	6.49e-07	3.62e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—LEP—asthma	6.49e-07	3.62e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—VEGFA—asthma	6.48e-07	3.61e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TGFB1—asthma	6.47e-07	3.6e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MMP9—asthma	6.44e-07	3.59e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—IL6—asthma	6.44e-07	3.59e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—STAT3—asthma	6.41e-07	3.57e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—PTEN—asthma	6.4e-07	3.57e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL1B—asthma	6.4e-07	3.57e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—CD4—asthma	6.4e-07	3.57e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCL2—asthma	6.4e-07	3.56e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL2—asthma	6.38e-07	3.55e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6R—asthma	6.38e-07	3.55e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—PTGS2—asthma	6.35e-07	3.54e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—EGFR—asthma	6.34e-07	3.53e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—POMC—asthma	6.3e-07	3.51e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—STAT3—asthma	6.29e-07	3.5e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—PTEN—asthma	6.26e-07	3.49e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—TGFB1—asthma	6.23e-07	3.47e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CXCL8—asthma	6.22e-07	3.47e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALOX5—asthma	6.21e-07	3.46e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TGFB1—asthma	6.2e-07	3.45e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL6—asthma	6.19e-07	3.45e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCL2—asthma	6.17e-07	3.43e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6R—asthma	6.15e-07	3.42e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—VEGFA—asthma	6.14e-07	3.42e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—FN1—asthma	6.12e-07	3.41e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—EGFR—asthma	6.11e-07	3.4e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—STAT3—asthma	6.08e-07	3.39e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—EGFR—asthma	6.08e-07	3.39e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GSTP1—asthma	6.08e-07	3.38e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CXCL8—asthma	6.07e-07	3.38e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—STAT3—asthma	6.06e-07	3.38e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TGFB1—asthma	6.03e-07	3.36e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—PTEN—asthma	6e-07	3.34e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—HMOX1—asthma	5.99e-07	3.34e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ITPR1—asthma	5.98e-07	3.33e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SERPINE1—asthma	5.97e-07	3.33e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL2—asthma	5.95e-07	3.31e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CXCL8—asthma	5.95e-07	3.31e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TGFB1—asthma	5.95e-07	3.31e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CARM1—asthma	5.92e-07	3.3e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL6—asthma	5.92e-07	3.3e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CAT—asthma	5.91e-07	3.29e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—EGFR—asthma	5.91e-07	3.29e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CXCL8—asthma	5.85e-07	3.26e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—DCN—asthma	5.84e-07	3.25e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—EGFR—asthma	5.83e-07	3.25e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CXCL8—asthma	5.82e-07	3.24e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—STAT3—asthma	5.81e-07	3.24e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL2—asthma	5.8e-07	3.23e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL6—asthma	5.79e-07	3.22e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—VEGFA—asthma	5.78e-07	3.22e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—RHOA—asthma	5.76e-07	3.21e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SERPINE1—asthma	5.76e-07	3.21e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—STAT3—asthma	5.73e-07	3.19e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL6—asthma	5.71e-07	3.18e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NOS3—asthma	5.7e-07	3.18e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL2—asthma	5.68e-07	3.17e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALDH2—asthma	5.68e-07	3.16e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFB1—asthma	5.64e-07	3.14e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MMP9—asthma	5.63e-07	3.14e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—STAT3—asthma	5.6e-07	3.12e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—PTEN—asthma	5.6e-07	3.12e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL2—asthma	5.59e-07	3.12e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PLA2G4A—asthma	5.58e-07	3.11e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GSTM1—asthma	5.58e-07	3.11e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—POMC—asthma	5.58e-07	3.11e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL2—asthma	5.57e-07	3.1e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—RHOA—asthma	5.55e-07	3.09e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—PTEN—asthma	5.54e-07	3.09e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL6—asthma	5.54e-07	3.08e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—EGFR—asthma	5.53e-07	3.08e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—EGFR—asthma	5.51e-07	3.07e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL6—asthma	5.5e-07	3.06e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NOS3—asthma	5.49e-07	3.06e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MMP9—asthma	5.49e-07	3.06e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—PTEN—asthma	5.46e-07	3.04e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCL2—asthma	5.46e-07	3.04e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6R—asthma	5.44e-07	3.03e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL6—asthma	5.41e-07	3.01e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTT1—asthma	5.4e-07	3.01e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFB1—asthma	5.38e-07	3e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MMP9—asthma	5.38e-07	3e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—STAT3—asthma	5.37e-07	2.99e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—PTEN—asthma	5.35e-07	2.98e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFB1—asthma	5.31e-07	2.96e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MMP9—asthma	5.3e-07	2.95e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—asthma	5.29e-07	2.95e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—asthma	5.29e-07	2.95e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—asthma	5.28e-07	2.94e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MMP9—asthma	5.27e-07	2.93e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—PTEN—asthma	5.26e-07	2.93e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—PTEN—asthma	5.24e-07	2.92e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—EGFR—asthma	5.21e-07	2.9e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFB1—asthma	5.19e-07	2.89e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—asthma	5.17e-07	2.88e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PPP2CA—asthma	5.14e-07	2.86e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—asthma	5.14e-07	2.86e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—asthma	5.1e-07	2.84e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SERPINE1—asthma	5.1e-07	2.84e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—EGFR—asthma	5.09e-07	2.83e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—asthma	5.09e-07	2.83e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—asthma	5.06e-07	2.82e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CXCL8—asthma	5.06e-07	2.82e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—VEGFA—asthma	5.06e-07	2.82e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—STAT3—asthma	5.01e-07	2.79e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—asthma	4.99e-07	2.78e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—STAT3—asthma	4.96e-07	2.76e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—VEGFA—asthma	4.93e-07	2.75e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—RHOA—asthma	4.92e-07	2.74e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—STAT3—asthma	4.88e-07	2.72e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—EGFR—asthma	4.88e-07	2.72e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CXCL8—asthma	4.87e-07	2.72e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—asthma	4.87e-07	2.71e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NOS3—asthma	4.86e-07	2.71e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL2—asthma	4.83e-07	2.69e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—VEGFA—asthma	4.83e-07	2.69e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—asthma	4.81e-07	2.68e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—STAT3—asthma	4.78e-07	2.66e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—VEGFA—asthma	4.75e-07	2.65e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—VEGFA—asthma	4.73e-07	2.63e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—STAT3—asthma	4.71e-07	2.62e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—asthma	4.7e-07	2.62e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—STAT3—asthma	4.68e-07	2.61e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—asthma	4.67e-07	2.6e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL2—asthma	4.66e-07	2.59e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFB1—asthma	4.64e-07	2.58e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFB1—asthma	4.59e-07	2.56e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MMP9—asthma	4.57e-07	2.55e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—EGFR—asthma	4.55e-07	2.53e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—PTEN—asthma	4.55e-07	2.53e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—asthma	4.54e-07	2.53e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFB1—asthma	4.53e-07	2.52e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—EGFR—asthma	4.5e-07	2.51e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NQO1—asthma	4.49e-07	2.5e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—asthma	4.48e-07	2.5e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—EGFR—asthma	4.44e-07	2.47e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFB1—asthma	4.43e-07	2.47e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MMP9—asthma	4.41e-07	2.46e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—asthma	4.39e-07	2.45e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ADCY2—asthma	4.39e-07	2.45e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—PTEN—asthma	4.38e-07	2.44e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFB1—asthma	4.36e-07	2.43e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—EGFR—asthma	4.35e-07	2.42e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFB1—asthma	4.34e-07	2.42e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CXCL8—asthma	4.32e-07	2.4e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—EGFR—asthma	4.28e-07	2.38e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—EGFR—asthma	4.26e-07	2.37e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—asthma	4.25e-07	2.37e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—asthma	4.23e-07	2.36e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL2—asthma	4.12e-07	2.3e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—VEGFA—asthma	4.11e-07	2.29e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—STAT3—asthma	4.07e-07	2.27e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—asthma	4.06e-07	2.26e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—asthma	4e-07	2.23e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—VEGFA—asthma	3.96e-07	2.21e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—POMC—asthma	3.95e-07	2.2e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—STAT3—asthma	3.92e-07	2.18e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—asthma	3.91e-07	2.18e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MMP9—asthma	3.9e-07	2.17e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PTEN—asthma	3.88e-07	2.16e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFB1—asthma	3.77e-07	2.1e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—asthma	3.75e-07	2.09e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTP1—asthma	3.74e-07	2.09e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—HMOX1—asthma	3.69e-07	2.06e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ITPR1—asthma	3.68e-07	2.05e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CAT—asthma	3.64e-07	2.03e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFB1—asthma	3.63e-07	2.02e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ALB—asthma	3.6e-07	2e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—EGFR—asthma	3.56e-07	1.98e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—VEGFA—asthma	3.5e-07	1.95e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—asthma	3.5e-07	1.95e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—STAT3—asthma	3.47e-07	1.93e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—asthma	3.46e-07	1.93e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—NOS3—asthma	3.44e-07	1.92e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PLA2G4A—asthma	3.44e-07	1.92e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTM1—asthma	3.44e-07	1.92e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—asthma	3.41e-07	1.9e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—asthma	3.34e-07	1.86e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—asthma	3.29e-07	1.83e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—asthma	3.27e-07	1.82e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFB1—asthma	3.22e-07	1.79e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PPP2CA—asthma	3.17e-07	1.76e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—EGFR—asthma	3.15e-07	1.76e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTGS2—asthma	3.15e-07	1.75e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—asthma	2.84e-07	1.58e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTEN—asthma	2.75e-07	1.53e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—asthma	2.74e-07	1.53e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—POMC—asthma	2.43e-07	1.35e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—asthma	2.42e-07	1.35e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALB—asthma	2.22e-07	1.23e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NOS3—asthma	2.12e-07	1.18e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS2—asthma	1.94e-07	1.08e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTEN—asthma	1.69e-07	9.42e-07	CbGpPWpGaD
